pembrolizumab,NT-I7
merck,neoimmunetech
['pembro', 'neoimmune']
#neoimmunetechs #nti7 creates a more #immunogenic #tumormicroenvironment when associated with #pembrolizumab #esmo22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.